[1]
Khandelwal, P.N., H. Maaz, S. and Borade, D.M. 2018. Evaluation of efficacy and safety of doxofylline 800mg sustained release tablet in treatment of patients with COPD: an open label, prospective and RCT. International Journal of Basic & Clinical Pharmacology. 7, 4 (Mar. 2018), 644–649. DOI:https://doi.org/10.18203/2319-2003.ijbcp20181163.